Overview
Kedrion Biopharma's portfolio focuses on life saving products derived from human plasma. There are many benefits of plasma products for the medical community. The plasma proteins are isolated and processed for final distribution. These proteins are used for people with congenital disorders such as Hemophilia A or Primary Immune Deficiency. Other plasma derived products like albumin may be used in critical situations to treat wounds, burns and trauma.
Kedrion focuses its resources in 3 specific areas: